Hong Kong Pharma (HKPD) | Stock Overview & Key Data
Hong Kong Pharma Digital Technology Co. Ltd. | Micro-cap | Healthcare
Hong Kong Pharma Digital Technology Co. Ltd. | Micro-cap | Healthcare
Hong Kong Pharma Performance Comparison
Stock Range
Today's Range
Low: $0.96
High: $1.03
on August 21, 2025
52 Week Range
Low: $0.81
High: $3.79
on May 8, 2025
on January 15, 2025
All-Time High: $3.79 on January 13, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$11.5M
EPS
0.00
P/E Ratio (TTM)
6.26
Forward P/E
N/A
P/B Ratio
2.31
PEG Ratio
N/A
Div. Yield
N/A
ROE
-0.59%
Beta
N/A
Debt to Equity
47.60
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-9.05%
Profit Margin
-0.13%
Returns and Earnings
Return on Assets (TTM)
1.32%
Return on Equity (TTM)
-0.59%
EBITDA
$1.3M
Net Income (TTM)
$-27.1K
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$1.85
Quarterly Revenue Growth (YoY)
-4.70%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Hong Kong Pharma HKPD | 11.55M Micro-cap | -8.18% | -25.74% | -4.72% | -42.94% | -64.18% | -63.27% | -63.27% | -63.27% |
| Walgreens Boots WBA | 10.46B Large-cap | 2.61% | 5.90% | 8.64% | 16.08% | 32.75% | 18.45% | -66.11% | -68.52% |
| High Tide HITI | 248.48M Micro-cap | 25.20% | 28.87% | 31.06% | 19.38% | -7.23% | 57.14% | 115.38% | -2.22% |
| PetMed Express PETS | 62.59M Micro-cap | -2.80% | -8.50% | -22.39% | -29.25% | -32.76% | 0.65% | -84.56% | -91.00% |
| Wellgistics Health WGRX | 56.79M Micro-cap | 17.14% | -30.51% | -69.17% | -78.48% | -78.48% | -78.48% | -78.48% | -78.48% |
| Scienture Holdings SCNX | 19.52M Micro-cap | -51.80% | -50.00% | 16.30% | -60.81% | -82.17% | -86.47% | -94.20% | -98.76% |
Ownership & Short Interest
Insider Ownership
68.01%
Institutional Ownership
0.67%
Shares Short
36K
Short Ratio
0.25
Short % of Shares Outstanding
0.77%
Average 10-Day Volume
37K
Average 90-Day Volume
85K
Hong Kong Pharma Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Hong Kong Pharma would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is HKPD's 52-week high and low?
- In the last 52 weeks, Hong Kong Pharma reached a high of $3.79 (on January 15, 2025) and a low of $0.81 (on May 8, 2025).
- What is the market cap and P/E ratio for HKPD?
- Curious about Hong Kong Pharma's size and valuation? Its market capitalization stands at 11.55M. When it comes to valuation, the P/E ratio (trailing twelve months) is 6.26, and the forward P/E (looking ahead) is N/A.
- Does HKPD pay dividends? If so, what's the yield?
- As for dividends, Hong Kong Pharma isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Hong Kong Pharma's main competitors or similar companies to consider before investing?
When looking at Hong Kong Pharma, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Walgreens Boots
WBA10.46B Healthcare Pharmaceutical Retailers 18.45% -66.11% High Tide
HITI248.48M Healthcare Pharmaceutical Retailers 57.14% 115.38% PetMed Express
PETS62.59M Healthcare Pharmaceutical Retailers 0.65% -84.56% Wellgistics Health
WGRX56.79M Healthcare Pharmaceutical Retailers -78.48% -78.48% Scienture Holdings
SCNX19.52M Healthcare Pharmaceutical Retailers -86.47% -94.20% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Hong Kong Pharma Digital Technology Co. Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Hong Kong Pharma's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -0.59%, the Debt to Equity ratio from the most recent quarter is 47.60, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for HKPD?
- Looking at Hong Kong Pharma's growth, its revenue over the trailing twelve months (TTM) was $20M. Compared to the same quarter last year (YoY), quarterly revenue grew by -4.70%, and quarterly earnings saw a YoY growth of N/A.
- How much of HKPD stock is held by insiders and institutions?
- Wondering who owns Hong Kong Pharma stock? Company insiders (like executives and directors) hold about 68.01% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.67%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.